Anthropic Secures $30 Billion in Series G Funding
Anthropic's Meteoric Rise: Hits $380B Valuation in Latest Funding Blitz
Anthropic, creator of the Claude chatbot, has just announced a stunning $30 billion Series G funding round, rocketing its valuation to an astounding $380 billion. The aggressive capital inflow not only doubles its previous valuation but also steadies its position among the world's most valuable private companies, just behind giants like OpenAI and SpaceX. With significant backing from GIC and Coatue, Anthropic plans to turbocharge its enterprise AI tools and continue its frontier research to compete in the heated AI race.
Introduction to Anthropic's Latest Funding Round
Key Players in Series G Round
Anthropic vs. OpenAI: A Valuation and Strategy Comparison
Financial Trajectory: Revenue Growth and Profitability
Product Innovations and Market Position
Founders, History, and Differentiation
Use of Funds and IPO Prospects
Major Investors and Customer Base
Economic Impact of Anthropic's Funding
Social and Workforce Implications
Political and Regulatory Considerations
Related News
Apr 24, 2026
Singapore Tops Global Per Capita Usage of Anthropic’s Claude AI
Singapore leads the world in per capita adoption of Anthropic's Claude AI model, reflecting a rapid integration of AI in business. GIC's senior VP Dominic Soon highlights the massive benefits of responsible AI deployment at a recent GIC-Anthropic event. With a US$1.5 billion investment in Anthropic, GIC underscores its commitment to AI development.
Apr 24, 2026
DeepSeek's Open-Source A.I. Surge: Game Changer in Global Competition
DeepSeek's release of its open-source V4 model propels its position in the A.I. race, challenging American giants with cost-efficiency and openness. For global builders, this marks a new era of accessible, powerful tools for software development.
Apr 24, 2026
White House Hits Back at China's Alleged AI Tech Theft
A White House memo has accused Chinese firms of large-scale AI technology theft. Michael Kratsios warns of systematic tactics undermining US R&D. No specific punitive measures detailed yet.